{"transactions":[{"id":1594401,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-03-06T00:00:05.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":335,"price":0.958,"value":320.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":10643,"source":{"system":"sec-edgar","filing":"0001683168-24-001324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824001324/ownership.xml","form_type":"4"}},{"id":1632737,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-02-21T00:03:51.000Z","date":"2024-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":523,"price":0.66,"value":345.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":10978,"source":{"system":"sec-edgar","filing":"0001683168-24-001086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824001086/ownership.xml","form_type":"4"}},{"id":1632736,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2024-02-21T00:03:51.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":658,"price":0.65,"value":427.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":11501,"source":{"system":"sec-edgar","filing":"0001683168-24-001086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316824001086/ownership.xml","form_type":"4"}},{"id":1971912,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-03-03T23:00:26.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":335,"price":5.49,"value":1839.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":12159,"source":{"system":"sec-edgar","filing":"0001209191-23-015880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123015880/doc4.xml","form_type":"4"}},{"id":1998891,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-23T00:05:19.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":12494,"source":{"system":"sec-edgar","filing":"0001209191-23-011911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123011911/doc4.xml","form_type":"4"}},{"id":2006627,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-17T23:30:20.000Z","date":"2023-02-15","kind":"tax_withholding","acquired":false,"shares":657,"price":5.2,"value":3416.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":7994,"source":{"system":"sec-edgar","filing":"0001209191-23-010876","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919123010876/doc4.xml","form_type":"4"}},{"id":2353000,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-03-04T00:13:32.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":4011,"price":0.821,"value":3293.031,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":103815,"source":{"system":"sec-edgar","filing":"0001209191-22-015894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122015894/doc4.xml","form_type":"4"}},{"id":2391341,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-17T01:10:37.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":68000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":107826,"source":{"system":"sec-edgar","filing":"0001209191-22-010402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919122010402/doc4.xml","form_type":"4"}},{"id":2811645,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-04T02:00:12.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":34600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55."}],"balance_after":39826,"source":{"system":"sec-edgar","filing":"0001209191-21-017568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919121017568/doc4.xml","form_type":"4"}},{"id":3363921,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2019-11-21T00:32:32.000Z","date":"2019-11-18","kind":"grant","acquired":true,"shares":237500,"price":0.1,"value":23750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":279030,"source":{"system":"sec-edgar","filing":"0001209191-19-057506","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919119057506/doc4.xml","form_type":"4"}},{"id":3448745,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & VP Finance & Admin"}}],"security":"Common stock, $0.0001 par value","published_at":"2019-08-03T00:34:01.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":749,"price":0.403,"value":301.847,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in\nconnection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":41530,"source":{"system":"sec-edgar","filing":"0001209191-19-044365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919119044365/doc4.xml","form_type":"4"}},{"id":3653248,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & Sr. Dir. Finance"}}],"security":"Common stock","published_at":"2019-02-16T02:02:54.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments."}],"balance_after":40214,"source":{"system":"sec-edgar","filing":"0001209191-19-010822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919119010822/doc4.xml","form_type":"4"}},{"id":3852763,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & Dir. of Finance"}}],"security":"Stock option (right to buy)","published_at":"2018-08-04T01:28:06.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in four equal annual installments."}],"balance_after":10500,"derivative":{"exercise_price":1.79,"expiration_date":"2028-08-01","underlying":"Common stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001209191-18-045454","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919118045454/doc4.xml","form_type":"4"}},{"id":3852762,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & Dir. of Finance"}}],"security":"Common Stock","published_at":"2018-08-04T01:28:06.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments."}],"balance_after":11024,"source":{"system":"sec-edgar","filing":"0001209191-18-045454","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919118045454/doc4.xml","form_type":"4"}},{"id":4467902,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":93467,"kind":"person","name":"Kontulis Caitlin","position":1,"cik":"0001570511","reported_name":"Kontulis Caitlin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary & Dir. of Finance"}}],"security":"Stock option (right to buy)","published_at":"2017-02-03T22:16:09.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests 12.5% on the six month anniversary of the grant date, 12.5% on the one year anniversary of the grant date, and 25% on\neach of the second, third, and fourth anniversaries of the grant date thereafter."}],"balance_after":2500,"derivative":{"exercise_price":0.629,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-17-007722","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533040/000120919117007722/doc4.xml","form_type":"4"}}]}